Hesham G Al-Inany
Overview
Explore the profile of Hesham G Al-Inany including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
818
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abou-Setta A, Jeyaraman M, Attia A, Al-Inany H, Ferri M, Ansari M, et al.
PLoS One
. 2017 Feb;
12(2):e0172372.
PMID: 28192493
[This corrects the article DOI: 10.1371/journal.pone.0165903.].
2.
Abou-Setta A, Jeyaraman M, Attia A, Al-Inany H, Ferri M, Ansari M, et al.
PLoS One
. 2016 Dec;
11(12):e0165903.
PMID: 27930662
Introduction: Rapid reviews (RR), using abbreviated systematic review (SR) methods, are becoming more popular among decision-makers. This World Health Organization commissioned study sought to summarize RR methods, identify differences, and...
3.
Al-Inany H, Youssef M, Ayeleke R, Brown J, Lam W, Broekmans F
Cochrane Database Syst Rev
. 2016 Apr;
4:CD001750.
PMID: 27126581
Background: Gonadotrophin-releasing hormone (GnRH) antagonists can be used to prevent a luteinizing hormone (LH) surge during controlled ovarian hyperstimulation (COH) without the hypo-oestrogenic side-effects, flare-up, or long down-regulation period associated...
4.
Youssef M, van der Veen F, Al-Inany H, Mochtar M, Griesinger G, Aboulfoutoh I, et al.
Reprod Biomed Online
. 2015 Dec;
32(2):259-60.
PMID: 26655648
No abstract available.
5.
Youssef M, Mantikou E, van Wely M, van der Veen F, Al-Inany H, Repping S, et al.
Cochrane Database Syst Rev
. 2015 Nov;
(11):CD007876.
PMID: 26585317
Background: Many media are commercially available for culturing pre-implantation human embryos in assisted reproductive technology (ART) cycles. It is unknown which culture medium leads to the best success rates after...
6.
Youssef M, van der Veen F, Al-Inany H, Mochtar M, Griesinger G, Mohesen M, et al.
Cochrane Database Syst Rev
. 2014 Nov;
(10):CD008046.
PMID: 25358904
Background: Human chorionic gonadotropin (HCG) is routinely used for final oocyte maturation triggering in in vitro fertilisation (IVF)/intracytoplasmic sperm injection (ICSI) cycles, but the use of HCG for this purpose...
7.
Abou-Setta A, Peters L, DAngelo A, Sallam H, Hart R, Al-Inany H
Cochrane Database Syst Rev
. 2014 Aug;
(8):CD006567.
PMID: 25157849
Background: In women undergoing in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI), embryos transferred into the uterine cavity can be expelled due to many factors including uterine peristalsis and...
8.
Attia A, Abou-Setta A, Al-Inany H
Cochrane Database Syst Rev
. 2013 Aug;
(8):CD005071.
PMID: 23970458
Background: Male factors leading to subfertility account for at least half of all cases of subfertility worldwide. Although some causes of male subfertility are treatable, treatment of idiopathic male factor...
9.
Abou-Setta A, Houston B, Al-Inany H, Farquhar C
Cochrane Database Syst Rev
. 2013 Feb;
(1):CD005072.
PMID: 23440798
Background: Various options exist for treating endometriosis, including surgical, medical, such as ovarian suppression, or a combination of these strategies. Surgical treatment of endometriosis aims to remove visible areas of...
10.
van Wely M, Kwan I, Burt A, Thomas J, Vail A, van der Veen F, et al.
Hum Reprod Update
. 2012 Feb;
18(2):111.
PMID: 22301671
No abstract available.